Open, robotic RP show few differences in pain, cost
Nashville, TN--As institutions accrue more experience with robotic-assisted laparoscopic radical prostatectomy, they are beginning to perform outcomes analyses to evaluate the pros and cons of the procedure compared with traditional open retropubic radical prostatectomy.
Jessica Feehan, NP-C, discusses the expanding role of APPs in urology, from clinical leadership and procedures to care coordination and treatment initiation.
Sam S. Chang, MD, MBA, discusses treatment selection after BCG failure, including bladder-sparing options, cystectomy considerations, and the need for sequencing data.
Justin B. Ziemba, MD, discusses clinical factors that help identify patients at increased risk for kidney stone recurrence and guide metabolic evaluation.
Adam Sharp, PhD, BM, MRCP, BSc, discusses preliminary safety and efficacy findings from a phase 1/2 study of gedatolisib plus darolutamide in patients with mCRPC.